maximizing Oncology analysis with built-in KRAS Assay expert services and RAS Assays
In the quickly evolving area of oncology study, correct and efficient mutation screening is crucial for establishing focused therapies. The KRAS products and services Platform plays a pivotal position On this landscape by offering complete solutions for KRAS mutation profiling and Investigation. KRAS mutations, found in roughly 95% of RAS-associate